What is the latest evidence on the use of metformin to prevent antipsychotic-induced weight gain?

Metformin shows efficacy in reducing weight gain and improving metabolic outcomes in patients on antipsychotic medications, with a consistent safety profile across studies.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-26
DOI
https://doi.org/10.5281/zenodo.23669216
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What is the latest evidence on the use of metformin to prevent antipsychotic-induced weight gain?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Schizophrenia research and treatment
article

What is the latest evidence on the use of metformin to prevent antipsychotic-induced weight gain?

Tripdatabase
article en

Abstract

Metformin shows efficacy in reducing weight gain and improving metabolic outcomes in patients on antipsychotic medications, with a consistent safety profile across studies.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 12%
Schizophrenia research and treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What is the latest evidence on the use of metformin to prevent antipsychotic-induced weight gain? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS